Longeveron Total Non Current Liabilities 2011-2026 | LGVN

Annual Total Non Current Liabilities Longeveron

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
499 K	1.09 M	1.45 M	2.04 M	-	3.45 M	3.65 M	1.84 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
3.65 M	499 K	2 M

Quarterly Total Non Current Liabilities Longeveron

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
838 K	651 K	809 K	966 K	1.18 M	1.27 M	1.36 M	1.6 M	1.75 M	-	2.04 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
2.04 M	651 K	1.25 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	79.1 K	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	158 K	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
AstraZeneca PLC AZN	34.7 B	-	-	$ 96.9 B	Britain
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	876 K	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	7.32 M	-	0.74 %	$ 768 M	Israel
Galera Therapeutics GRTX	64 M	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	645 K	-	-18.52 %	$ 27.3 M	Britain
Esperion Therapeutics ESPR	355 M	$ 3.13	-	$ 651 M	USA
Eton Pharmaceuticals ETON	4.56 M	$ 35.0	1.6 %	$ 942 M	USA
Forte Biosciences FBRX	10.5 M	$ 22.0	8.32 %	$ 285 M	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Celyad Oncology SA CYAD	4.97 M	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	22.3 M	-	-7.31 %	$ 87 M	USA
Generation Bio Co. GBIO	132 M	-	-	$ 344 M	USA
IMV IMV	8.95 M	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
BioNTech SE BNTX	622 M	$ 90.93	0.63 %	$ 22 B	Germany
Autolus Therapeutics plc AUTL	50.6 M	$ 1.65	1.85 %	$ 439 M	Britain
Ayala Pharmaceuticals AYLA	497 K	-	-	$ 7.46 M	Israel
Grifols, S.A. GRFS	10.6 B	$ 8.11	-0.98 %	$ 5.51 B	Spain
Cyclacel Pharmaceuticals CYCCP	1.06 M	-	-4.36 %	$ 27 M	USA
Heron Therapeutics HRTX	14.6 M	$ 0.87	3.09 %	$ 145 M	USA
Compugen Ltd. CGEN	31.3 M	$ 2.61	-3.51 %	$ 244 M	Israel
Anika Therapeutics ANIK	26.1 M	$ 15.02	-0.79 %	$ 215 M	USA
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	14 M	-	5.93 %	$ 314 M	Canada
Incyte Corporation INCY	315 M	$ 97.41	0.34 %	$ 19 B	USA
Ionis Pharmaceuticals IONS	1.28 B	$ 75.78	0.96 %	$ 12.1 B	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
Can-Fite BioPharma Ltd. CANF	1.19 M	$ 3.44	-0.58 %	$ 5.66 M	Israel
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	27.9 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
Coherus BioSciences CHRS	189 M	$ 1.57	3.97 %	$ 184 M	USA
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	8.11 M	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	167 M	$ 21.01	2.64 %	$ 2.67 B	USA
Allena Pharmaceuticals ALNA	10.2 M	-	3.16 %	$ 1.9 M	USA